Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT02590653

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Penza State University (from the registry)
Registry
  • NCT NCT02590653
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02590653. Randomized; no masking; primary purpose treatment. Start 2014-10 (actual); primary completion 2019-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
Acronym
CONTRAST
Intervention (Drug)
Atorvastatin
Lead sponsor
Penza State University (class: other)

Record details

Record id
cardio:ct-nct02590653
Content hash
87d60a5a8ee54bfd17543b70514a56062b8b0fd7232e7b82cae1daaab4543606